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CONTINENCE AND COMPLICATIONS RATES AFTER MALE SLINGS AS PRIMARY 
SURGERY FOR POST-PROSTATECTOMY INCONTINENCE: A SYSTEMATIC REVIEW 
 
Hypothesis / aims of study 
Radical prostatectomy (RP) is the most common treatment option for prostate cancer. Urinary incontinence (UI) is a common 
and costly complication in men after RP, often adversely affecting their quality of life. Despite improvements in surgical 
techniques and a better understanding of pelvic anatomy, the reported stress urinary incontinence (SUI) rates are between 5% 
and 48%. Conservative treatment of the urinary leakage represents the first line management of UI after RP, but the value of 
the various conservative approaches to treat postprostatectomy UI after RP remains uncertain. When conservative treatments 
are unsuccessful after a reasonable period of time, invasive therapies should be considered. According to the last International 
Consultation on Incontinence Recommendations, for SUI due to sphincter incompetence the recommended option is the 
artificial urinary sphincter (AUS) (Grade B); other options, such as a male sling, may be considered (Grade C). These low 
grades of recommendation can be explained by the fact that, although there are several options for surgical treatment of UI 
after prostatectomy, surprisingly only one randomised clinical trial was identified in the literature, comparing AUS implantation 
and injectable treatment with Macroplastique. For other surgical procedures such as male slings, Pro-ACT system, other 
bulking agents and stem-cell therapy, only non-randomised studies were identified, making impossible to answer questions 
about treatment comparison in terms of efficacy, safety, complications and long term results. The aim of this review was to 
analyze continence and complications rates after male slings as first line surgical treatment, in order to improve patient 
counseling for the management of SUI postprostatectomy. 
 
Study design, materials and methods 
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist was used to help guide this 
report [8]. We conducted a PubMed database search through January 2012 for relevant prospective cohort studies and case 
series that met the following inclusion criteria: English language; adults with SUI postprostatectomy who underwent male slings 
as first surgical option for continence recovery; studies carried out on ≥ 20 patients with a mean follow-up of ≥1 year; because 
the majority of papers dealing with outcome and complications came from a few centres, only the most recent publication(s) 
from each centre were included to avoid the same patients being presented several times. Multiple free-text searches were 
performed. In addition, other significant studies cited in the reference lists of the selected papers were considered. Few studies 
presented their original data in a format amenable to meta-analysis. A single weight-adjusted mean or proportion for each 
variable or outcome was computed for each of the nonrandomized studies. To derive pooled estimates of proportions for the 
outcomes explored, random effects models were used. Pooling was conducted using Comprehensive Meta Analysis Version 
2.2.046 (Englewood, NJ). Given that this review assessed measures of prevalence, publication bias was not evaluated.  
 
Results 
From screening 160 records, 49 full-text articles were retrieved with only 5 articles included in the systematic review (figure 1). 
The 5 included articles involved 356 participants living in 8 countries with a median follow-up after sling implant of 15 months 
(interquartile range, 12-21) and sling surgeries conducted between 2002 and 2009. Patients’ mean age at time of surgery was 
68.06 (standard deviation, 1.37) years. Study characteristics and quality are summarized in Table 1. No controlled trial was 
available for analysis. The majority of papers dealing with outcome and complications came from a few centres. 
 
Figure 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram.  
 
Table 1. Characteristics of included observational studies 
 
 
At a median follow-up of 15 months the pooled cure rates for all kinds of slings was 77.4% (95% CI 66.0-85.8); in the AdVance 
group the pooled cure rates was 72.5 (95% CI 65.0-68.8); in the InVance group it was 74.2% (95% CI 56.3-86.5) while in the 
Remeex group it was 84.3% (95% CI 71.6-92). Figure 2 pooled the continence rates achieved after the analysed sling 
procedures. 
 
Figure 2. Pooled analysis of reported overall cure rates.  
 
Interpretation of results 
The male slings approved for use currently include a variety of types: bone anchored slings, adjustable slings, and 
transobturator slings. This review tried to systematically assessed the outcomes of male slings used as the first line treatment, 
after conservative therapy failure, for the treatment of post-prostatectomy SUI. Only a few number of the observational studies 
published in the literature addressed review selection criteria. The pooled overall cure rates is high but there are no data 
concerning reliable pre- and postoperative prognostic factors affecting treatment failure and complications rates, thus it is not 
possible to have suitable criteria for a better patient selection. The statistically pooled results obtained should be interpreted 
with caution because of several limitations due to several study selection limitations: observational study design, few number of 
analysed studies, heterogeneity, lack of outcome definition and standardisation, between-study variability, high risk of bias. 
 
Concluding message 
In order to better select patients for male slings in the management of post-prostatectomy SUI as first line treatment, it is 
mandatory to carried out both well designed randomized clinical trials and longitudinal cohort studies, using standardised 
protocols and outcome measures.  
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